Preparation and in Vitro Antimicrobial Activity of Silver-Bearing Degradable Polymeric Nanoparticles of Polyphosphoester-block-Poly(l-lactide)
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
The development of well-defined polymeric nanoparticles (NPs) as delivery carriers for antimicrobials targeting human infectious diseases requires rational design of the polymer template, an efficient synthetic approach, and fundamental understanding of the developed NPs, e.g., drug loading/release, particle stability, and other characteristics. Herein, we developed and evaluated the in vitro antimicrobial activity of silver-bearing, fully biodegradable and functional polymeric NPs. A series of degradable polymeric nanoparticles (dNPs), composed of phosphoester and L-lactide and designed specifically for silver loading into the hydrophilic shell and/or the hydrophobic core, were prepared as potential delivery carriers for three different types of silver-based antimicrobials-silver acetate or one of two silver carbene complexes (SCCs). Silver-loading capacities of the dNPs were not influenced by the hydrophilic block chain length, loading site (i.e., core or shell), or type of silver compound, but optimization of the silver feed ratio was crucial to maximize the silver loading capacity of dNPs, up to ca. 12% (w/w). The release kinetics of silver-bearing dNPs revealed 50% release at ca. 2.5-5.5 h depending on the type of silver compound. In addition, we undertook a comprehensive evaluation of the rates of hydrolytic or enzymatic degradability and performed structural characterization of the degradation products. Interestingly, packaging of the SCCs in the dNP-based delivery system improved minimum inhibitory concentrations up to 70%, compared with the SCCs alone, as measured in vitro against 10 contemporary epidemic strains of Staphylococcus aureus and eight uropathogenic strains of Escherichia coli. We conclude that these dNP-based delivery systems may be beneficial for direct epithelial treatment and/or prevention of ubiquitous bacterial infections, including those of the skin and urinary tract.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552
A Literature Review of Poly(Lactic Acid)
Garlotta, D. (2001) · Journal of Polymers and the Environment · doi:10.1023/a:1020200822435 · Cited by 3,707 · cited 2×
“Its susceptibility to hydrolytic and/or enzymatic degradationand loadingofhydrophobic drugsmakepolylactide (PLA) popular as a building block for biomedical degradable polymers.(45,46) However, a lack of chemical functionality and intrinsic hydrophobicity limit its use as an intelligent delivery carrier itself.”
BackgroundDesign of polymeric nanoparticles for biomedical delivery applications
Elsabahy, M., & Wooley, K. L. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15327k · Cited by 1,717 · cited 1×
“therapeutic efficacy of active agents by improving drug delivery features such as solubility, encapsulation, etc.(26) Thus, we evaluated the in vitro antimicrobial”
BackgroundSelf-citationOvercoming the challenges in administering biopharmaceuticals: Formulation and delivery strategies
Mitragotri, S., Burke, P. A., & Langer, R. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4363 · Cited by 1,702
Athanasiou, K. A., Niederauer, G. G., & Agrawal, C. M. (1996) · Biomaterials · doi:10.1016/0142-9612(96)85754-1 · Cited by 1,497
Organocatalytic Ring-Opening Polymerization
Kamber, N. E., Jeong, W., Waymouth, R. M., Pratt, R. C., Lohmeijer, B. G. G., & Hedrick, J. L. (2007) · Chemical Reviews · doi:10.1021/cr068415b · Cited by 1,489
Bacterial silver resistance: molecular biology and uses and misuses of silver compounds
Silver, S. (2003) · FEMS Microbiology Reviews · doi:10.1016/s0168-6445(03)00047-0 · Cited by 1,312
Silver bromide nanoparticle/polymer composites: dual action tunable antimicrobial materials
Sambhy, V., MacBride, M. M., Peterson, B. R., & Sen, A. (2006) · Journal of the American Chemical Society · doi:10.1021/ja061442z · Cited by 748
Tempelaar, S., Mespouille, L., Coulembier, O., Dubois, P., & Dove, A. P. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35268k · Cited by 345
Wang, X., Xie, X., Cai, C., Rytting, E., Steele, T., & Kissel, T. (2008) · Macromolecules · doi:10.1021/ma702705s · Cited by 44
Cited by
Kamaly, N., Yameen, B., Wu, J., & Farokhzad, O. C. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00346 · Cited by 3,070
Biomedical Applications of Silver Nanoparticles: An Up-to-Date Overview
Burdușel, A.-C., Gherasim, O., Grumezescu, A. M., Mogoantă, L., Ficai, A., & Andronescu, E. (2018) · Nanomaterials · doi:10.3390/nano8090681 · Cited by 1,343
Polymeric Nanostructures for Imaging and Therapy
Elsabahy, M., Heo, G. S., Lim, S.-M., Sun, G., & Wooley, K. L. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00135 · Cited by 508
Self-citationUrinary Tract Infection: Pathogenesis and Outlook
McLellan, L. K., & Hunstad, D. A. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.09.003 · Cited by 382
Self-citationLiu, Y., Busscher, H. J., Zhao, B., Li, Y., Zhang, Z., van der Mei, H. C., Ren, Y., & Shi, L. (2016) · ACS Nano · doi:10.1021/acsnano.6b01370 · Cited by 379
Biomedical applications of nanodiamond (Review)
Turcheniuk, K., & Mochalin, V. N. (2017) · Nanotechnology · doi:10.1088/1361-6528/aa6ae4 · Cited by 324
Bauer, K. N., Tee, H. T., Velencoso, M. M., & Wurm, F. R. (2017) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2017.05.004 · Cited by 189
Hupfeld, T., Wegner, A., Blanke, M., Doñate‐Buendía, C., Sharov, V., Nieskens, S., Piechotta, M., Giese, M., Barcikowski, S., & Gökce, B. (2020) · Advanced Optical Materials · doi:10.1002/adom.202000473 · Cited by 42
Metadata
- Authors
- Lim, Y. H., Tiemann, K. M., Heo, G. S., Wagers, P. O., Rezenom, Y. H., Zhang, S., Zhang, F., Youngs, W. J., Hunstad, D. A., & Wooley, K. L.
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2015-01-26
- Volume
- 9
- Issue
- 2
- Pages
- 1995-2008
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- OpenAlex
- W2057344665
- Cited by
- 96
- References
- 10
- FWCI
- 4.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.